Comprehensive gene and pathway analysis of cervical cancer progression
- Authors:
- Yuexiong Yi
- Yan Fang
- Kejia Wu
- Yanyan Liu
- Wei Zhang
-
Affiliations: Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China - Published online on: March 3, 2020 https://doi.org/10.3892/ol.2020.11439
- Pages: 3316-3332
-
Copyright: © Yi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
 |
|
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Muliira RS, Salas AS and O'Brien B: Quality of life among female cancer survivors in Africa: An integrative literature review. Asia Pac J Oncol Nurs. 4:6–17. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Gravitt PE and Winer RL: Natural history of HPV infection across the lifespan: Role of viral latency. Viruses. 9:E2672017. View Article : Google Scholar : PubMed/NCBI | |
|
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Louie KS, de Sanjose S, Diaz M, Castellsagué X, Herrero R, Meijer CJ, Shah K, Franceschi S, Muñoz N and Bosch FX; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group, : Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer. 100:1191–1197. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Liu ZC, Liu WD, Liu YH, Ye XH and Chen SD: Multiple sexual partners as a potential independent risk factor for cervical cancer: A meta-analysis of epidemiological studies. Asian Pac J Cancer Prev. 16:3893–3900. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Smith JS, Green J, Berrington de Gonzalez A, Appleby P, Peto J, Plummer M, Franceschi S and Beral V: Cervical cancer and use of hormonal contraceptives: A systematic review. Lancet. 361:1159–1167. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Ma YY, Wei SJ, Lin YC, Lung JC, Chang TC, Whang-Peng J, Liu JM, Yang DM, Yang WK and Shen CY: PIK3CA as an oncogene in cervical cancer. Oncogene. 19:2739–2744. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng L, Li T, Zhang Y, Guo Y, Yao J, Dou L and Guo K: Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer. Oncol Rep. 33:2337–2344. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Bai X, Wang W, Zhao P, Wen J, Guo X, Shen T, Shen J and Yang X: LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression. Carcinogenesis. Oct 12–2019.(Epub ahead of print). | |
|
Bremer GL, Tieboschb AT, van der Putten HW, de Haan J and Arends JW: p53 tumor suppressor gene protein expression in cervical cancer: Relationship to prognosis. Eur J Obstet Gynecol Reprod Biol. 63:55–59. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Cohen Y, Singer G, Lavie O, Dong SM, Beller U and Sidransky D: The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix. Clin Cancer Res. 9:2981–2984. 2003.PubMed/NCBI | |
|
Hasina R, Pontier AL, Fekete MJ, Martin LE, Qi XM, Brigaudeau C, Pramanik R, Cline EI, Coignet LJ and Lingen MW: NOL7 is a nucleolar candidate tumor suppressor gene in cervical cancer that modulates the angiogenic phenotype. Oncogene. 25:588–598. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Roura E, Castellsagué X, Pawlita M, Travier N, Waterboer T, Margall N, Bosch FX, de Sanjosé S, Dillner J, Gram IT, et al: Smoking as a major risk factor for cervical cancer and pre-cancer: Results from the EPIC cohort. Int J cancer. 135:453–466. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Husain RS and Ramakrishnan V: Global variation of human papillomavirus genotypes and selected genes involved in cervical malignancies. Ann Glob Health. 81:675–683. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Soto D, Song C and McLaughlin-Drubin ME: Epigenetic alterations in human papillomavirus-associated cancers. Viruses. 9:E2482017. View Article : Google Scholar : PubMed/NCBI | |
|
Mincheva A, Gissmann L and zur Hausen H: Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med Microbiol Immunol. 176:245–256. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Senapati R, Senapati NN and Dwibedi B: Molecular mechanisms of HPV mediated neoplastic progression. Infect Agent Cancer. 11:592016. View Article : Google Scholar : PubMed/NCBI | |
|
Münger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M, Grace M and Huh K: Mechanisms of human papillomavirus-induced oncogenesis. J Virol. 78:11451–11460. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Martinez-Zapien D, Ruiz FX, Poirson J, Mitschler A, Ramirez J, Forster A, Cousido-Siah A, Masson M, Vande Pol S, Podjarny A, et al: Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53. Nature. 529:541–545. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Scheffner M, Huibregtse JM, Vierstra RD and Howley PM: The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 75:495–505. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Sherr CJ: The Pezcoller lecture: Cancer cell cycles revisited. Cancer Res. 60:3689–3695. 2000.PubMed/NCBI | |
|
Martin LG, Demers GW and Galloway DA: Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E. J Virol. 72:975–985. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Löffler H, Fechter A, Matuszewska M, Saffrich R, Mistrik M, Marhold J, Hornung C, Westermann F, Bartek J and Krämer A: Cep63 recruits Cdk1 to the centrosome: Implications for regulation of mitotic entry, centrosome amplification, and genome maintenance. Cancer Res. 71:2129–2139. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Skyldberg B, Fujioka K, Hellström AC, Sylvén L, Moberger B and Auer G: Human papillomavirus infection, centrosome aberration, and genetic stability in cervical lesions. Mod Pathol. 14:279–284. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Duensing S and Münger K: The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res. 62:7075–7082. 2002.PubMed/NCBI | |
|
Chaiwongkot A, Niruthisard S, Kitkumthorn N and Bhattarakosol P: Quantitative methylation analysis of human papillomavirus 16 L1 gene reveals potential biomarker for cervical cancer progression. Diagn Microbiol Infect Dis. 89:265–270. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma A, De R, Javed S, Srinivasan R, Pal A and Bhattacharyya S: Sonic hedgehog pathway activation regulates cervical cancer stem cell characteristics during epithelial to mesenchymal transition. J Cell Physiol. Feb 4–2019.(Epub ahead of print). View Article : Google Scholar | |
|
Li YP, Zhang L, Zou YL and Yu Y: Association between FGFR4 gene polymorphism and high-risk HPV infection cervical cancer. Asian Pac J Trop Med. 10:680–684. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J and Gao Y: CCAT-1 promotes proliferation and inhibits apoptosis of cervical cancer cells via the Wnt signaling pathway. Oncotarget. 8:68059–68070. 2017.PubMed/NCBI | |
|
Mora-García ML, Ávila-Ibarra LR, García-Rocha R, Weiss-Steider B, Hernández-Montes J, Don-López CA, Gutiérrez-Serrano V, Titla-Vilchis IJ, Fuentes-Castañeda MC, Monroy-Mora A, et al: Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway. Cell Immunol. 320:46–55. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Song ZC, Ding L, Ren ZY, Sun XS, Yang Q, Wang L, Feng MJ, Liu CL and Wang JT: Effects of Src on cervical cancer cells proliferation and apoptosis through ERK signal transduction pathway. Zhonghua Liu Xing Bing Xue Za Zhi. 38:1246–1251. 2017.(In Chinese; Abstract available in Chinese from the publisher). PubMed/NCBI | |
|
Xu Z, Zhou Y, Shi F, Cao Y, Dinh TLA, Wan J and Zhao M: Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis. Oncol Lett. 13:2784–2790. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chen SZ, Ma WL and Zheng WL: Screening for cervical cancer-related genes and their bioinformatics analysis. Nan Fang Yi Ke Da Xue Xue Bao. 28:585–588. 2008.(In Chinese). PubMed/NCBI | |
|
Nayar R and Wilbur DC: The bethesda system for reporting cervical cytology: A historical perspective. Acta Cytol. 61:359–372. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Shoji T, Takatori E, Takeuchi S, Yoshizaki A, Uesugi N, Sugai T and Sugiyama T: Clinical significance of atypical glandular cells in the bethesda system 2001: A comparison with the histopathological diagnosis of surgically resected specimens. Cancer Invest. 32:105–109. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
O'Connor M, Gallagher P, Waller J, Martin CM, O'Leary JJ and Sharp L; Irish Cervical Screening Research Consortium (CERVIVA), : Adverse psychological outcomes following colposcopy and related procedures: A systematic review. BJOG. 123:24–38. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Haque N, Uddin AFMK, Dey BR, Islam F and Goodman A: Challenges to cervical cancer treatment in Bangladesh: The development of a women's cancer ward at Dhaka Medical College Hospital. Gynecol Oncol Rep. 21:67–72. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Roque DR, Wysham WZ and Soper JT: The surgical management of cervical cancer: An overview and literature review. Obstet Gynecol Surv. 69:426–441. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Marin JJ, Romero MR, Blazquez AG, Herraez E, Keck E and Briz O: Importance and limitations of chemotherapy among the available treatments for gastrointestinal tumours. Anticancer Agents Med Chem. 9:162–184. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Chen HHW and Kuo MT: Improving radiotherapy in cancer treatment: Promises and challenges. Oncotarget. 8:62742–62758. 2017.PubMed/NCBI | |
|
Lecavalier-Barsoum M, Chaudary N, Han K, Pintilie M, Hill RP and Milosevic M: Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy. Br J Cancer. 121:249–256. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang F, Ren CC, Liu L, Chen YN, Yang L, Zhang XA, Wang XM and Yu FJ: SHH gene silencing suppresses epithelial-mesenchymal transition, proliferation, invasion, and migration of cervical cancer cells by repressing the hedgehog signaling pathway. J Cell Biochem. 119:3829–3842. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Gu J, Zhang X, Yang Z and Wang N: Expression of cyclin D1 protein isoforms and its prognostic significance in cervical cancer. Cancer Manag Res. 11:9073–9083. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chay DB, Han GH, Nam S, Cho H, Chung JY and Hewitt SM: Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer. Int J Clin Oncol. 24:1429–1439. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Tang H, Wang Y, Zhang B, Xiong S, Liu L, Chen W, Tan G and Li H: High brain acid soluble protein 1(BASP1) is a poor prognostic factor for cervical cancer and promotes tumor growth. Cancer Cell Int. 17:972017. View Article : Google Scholar : PubMed/NCBI | |
|
Yang X, Cheng Y and Li C: The role of TLRs in cervical cancer with HPV infection: A review. Signal Transduct Target Ther. 2:170552017. View Article : Google Scholar : PubMed/NCBI | |
|
Frumovitz M and Sood AK: Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies. Gynecol Oncol. 104:768–778. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
den Boon JA, Pyeon D, Wang SS, Horswill M, Schiffman M, Sherman M, Zuna RE, Wang Z, Hewitt SM, Pearson R, et al: Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling. Proc Natl Acad Sci USA. 112:E3255–E3264. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, et al: NCBI GEO: Archive for functional genomics data sets-update. Nucleic Acids Res. 41:D991–D995. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W and Smyth GK: Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43:e472015. View Article : Google Scholar : PubMed/NCBI | |
|
Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, et al: STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43:D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT and Lin CY: cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 8 (Suppl 4):S112014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Vasaikar S, Shi Z, Greer M and Zhang B: WebGestalt 2017: A more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit. Nucleic Acids Res. 45:W130–W137. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chen J, Bardes EE, Aronow BJ and Jegga AG: ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 37:W305–W311. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Hu Y, Pan Z, Hu Y, Zhang L and Wang J: Network and pathway-based analyses of genes associated with Parkinson's disease. Mol Neurobiol. 54:4452–4465. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Scardoni G, Petterlini M and Laudanna C: Analyzing biological network parameters with CentiScaPe. Bioinformatics. 25:2857–2859. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Han JD, Berlin N, Hao T, Goldberg DS, Berriz GF, Zhang LV, Dupuy D, Walhout AJ, Cusick ME, Roth FP and Vidal M: Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature. 430:88–93. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Kanwal A and Fazal S: Construction and analysis of protein-protein interaction network correlated with ankylosing spondylitis. Gene. 638:41–51. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wu J, Vallenius T, Ovaska K, Westermarck J, Mäkelä TP and Hautaniemi S: Integrated network analysis platform for protein-protein interactions. Nat Methods. 6:75–77. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kerrien S, Alam-Faruque Y, Aranda B, Bancarz I, Bridge A, Derow C, Dimmer E, Feuermann M, Friedrichsen A, Huntley R, et al: IntAct-source resource for molecular interaction data. Nucleic Acids Res. 35:D561–D565. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Chatr-aryamontri A, Ceol A, Palazzi LM, Nardelli G, Schneider MV, Castagnoli L and Cesareni G: MINT: The Molecular INTeraction database. Nucleic Acids Res. 35:D572–D574. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Breitkreutz BJ, Stark C, Reguly T, Boucher L, Breitkreutz A, Livstone M, Oughtred R, Lackner DH, Bähler J, Wood V, et al: The BioGRID interaction database: 2008 update. Nucleic Acids Res. 36:D637–D640. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Salwinski L, Miller CS, Smith AJ, Pettit FK, Bowie JU and Eisenberg D: The database of interacting proteins: 2004 update. Nucleic Acids Res. 32:D449–D451. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Peri S, Navarro JD, Amanchy R, Kristiansen TZ, Jonnalagadda CK, Surendranath V, Niranjan V, Muthusamy B, Gandhi TK, Gronborg M, et al: Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res. 13:2363–2371. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Güldener U, Münsterkötter M, Oesterheld M, Pagel P, Ruepp A, Mewes HW and Stümpflen V: MPact: The MIPS protein interaction resource on yeast. Nucleic Acids Res. 34:D436–D441. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Vasaikar SV, Straub P, Wang J and Zhang B: LinkedOmics: Analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 46:D956–D963. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Cancer Genome Atlas Research Network, ; Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C and Stuart JM: The cancer genome atlas pan-cancer analysis project. Nat Genet. 45:1113–1120. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Gasca S, Pellestor F, Assou S, Loup V, Anahory T, Dechaud H, De Vos J and Hamamah S: Identifying new human oocyte marker genes: A microarray approach. Reprod Biomed Online. 14:175–183. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Schwab MS, Roberts BT, Gross SD, Tunquist BJ, Taieb FE, Lewellyn AL and Maller JL: Bub1 is activated by the protein kinase p90(Rsk) during Xenopus oocyte maturation. Curr Biol. 11:141–150. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Ouandaogo ZG, Frydman N, Hesters L, Assou S, Haouzi D, Dechaud H, Frydman R and Hamamah S: Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo and in vitro oocyte maturation. Hum Reprod. 27:2438–2447. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Qian WP and Sun QY: Cyclins regulating oocyte meiotic cell cycle progression†. Biol Reprod. 101:878–881. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kaplan MH: STAT signaling in inflammation. JAKSTAT. 2:e241982013.PubMed/NCBI | |
|
Qiu X, Guo H, Yang J, Ji Y, Wu CS and Chen X: Down-regulation of guanylate binding protein 1 causes mitochondrial dysfunction and cellular senescence in macrophages. Sci Rep. 8:16792018. View Article : Google Scholar : PubMed/NCBI | |
|
Bros M, Haas K, Moll L and Grabbe S: RhoA as a key regulator of innate and adaptive immunity. Cells. 8:E7332019. View Article : Google Scholar : PubMed/NCBI | |
|
Erdely A, Antonini JM, Salmen-Muniz R, Liston A, Hulderman T, Simeonova PP, Kashon ML, Li S, Gu JK, Stone S, et al: Type I interferon and pattern recognition receptor signaling following particulate matter inhalation. Part Fibre Toxicol. 9:252012. View Article : Google Scholar : PubMed/NCBI | |
|
Luu K, Greenhill CJ, Majoros A, Decker T, Jenkins BJ and Mansell A: STAT1 plays a role in TLR signal transduction and inflammatory responses. Immunol Cell Biol. 92:761–769. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Smolen KK, Ruck CE, Fortuno ES III, Ho K, Dimitriu P, Mohn WW, Speert DP, Cooper PJ, Esser M, Goetghebuer T, et al: Pattern recognition receptor-mediated cytokine response in infants across 4 continents. J Allergy Clin Immunol. 133:818–826.e4. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Xiang C, Chen J and Fu P: HGF/Met signaling in cancer invasion: The impact on cytoskeleton remodeling. Cancers (Basel). 9:E442017. View Article : Google Scholar : PubMed/NCBI | |
|
Lei T and Ling X: IGF-1 promotes the growth and metastasis of hepatocellular carcinoma via the inhibition of proteasome-mediated cathepsin B degradation. World J Gastroenterol. 21:10137–10149. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Cho S, Kitadai Y, Yoshida S, Tanaka S, Yoshihara M, Yoshida K and Chayama K: Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach. Int J Oncol. 28:1361–1367. 2006.PubMed/NCBI | |
|
Li B, Shen W, Peng H, Li Y, Chen F, Zheng L, Xu J and Jia L: Fibronectin 1 promotes melanoma proliferation and metastasis by inhibiting apoptosis and regulating EMT. Onco Targets Ther. 12:3207–3221. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Ren CC, Yang L, Xu YM and Chen YN: Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro. J Cell Physiol. 234:3897–3909. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Y, Jiang J, Zhao M, Luo X, Liang Z, Zhen Y, Fu Q, Deng X, Lin X, Li L, et al: microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway. Oncotarget. 7:41306–41319. 2016.PubMed/NCBI | |
|
Thomas SJ, Snowden JA, Zeidler MP and Danson SJ: The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer. 113:365–371. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Stacker SA and Achen MG: The VEGF signaling pathway in cancer: The road ahead. Chin J Cancer. 32:297–302. 2013.PubMed/NCBI | |
|
Shi X, Wang J, Lei Y, Cong C, Tan D and Zhou X: Research progress on the PI3K/AKT signaling pathway in gynecological cancer (Review). Mol Med Rep. 19:4529–4535. 2019.PubMed/NCBI | |
|
Li X, Jiang S and Tapping RI: Toll-like receptor signaling in cell proliferation and survival. Cytokine. 49:1–9. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Gene Ontology Consortium: Gene ontology consortium: Going forward. Nucleic Acids Res. 43:D1049–D1056. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kawai T and Akira S: Toll-like receptor and RIG-1-like receptor signaling. Ann N Y Acad Sci. 1143:1–20. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Gkretsi V and Stylianopoulos T: Cell adhesion and matrix stiffness: Coordinating cancer cell invasion and metastasis. Front Oncol. 8:1452018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang YL, Wang RC, Cheng K, Ring BZ and Su L: Roles of Rap1 signaling in tumor cell migration and invasion. Cancer Biol Med. 14:90–99. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Campbell PM and Der CJ: Oncogenic Ras and its role in tumor cell invasion and metastasis. Semin Cancer Biol. 14:105–114. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Sun F, Wang J, Sun Q, Li F, Gao H, Xu L, Zhang J, Sun X, Tian Y, Zhao Q, et al: Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma. J Exp Clin Cancer Res. 38:4492019. View Article : Google Scholar : PubMed/NCBI | |
|
Sanderson RD: Heparan sulfate proteoglycans in invasion and metastasis. Semin Cell Dev Biol. 12:89–98. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Loo YM and Gale M Jr: Immune signaling by RIG-I-like receptors. Immunity. 34:680–692. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Nyati KK and Prasad KN: Role of cytokines and Toll-like receptors in the immunopathogenesis of Guillain-Barré syndrome. Mediators Inflamm. 2014:7586392014. View Article : Google Scholar : PubMed/NCBI | |
|
Saxena M and Yeretssian G: NOD-Like receptors: Master regulators of inflammation and cancer. Front Immunol. 5:3272014. View Article : Google Scholar : PubMed/NCBI | |
|
Crosbie EJ, Einstein MH, Franceschi S and Kitchener HC: Human papillomavirus and cervical cancer. Lancet. 382:889–899. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Balasubramaniam SD, Balakrishnan V, Oon CE and Kaur G: Key molecular events in cervical cancer development. Medicina (Kaunas). 55:E3842019. View Article : Google Scholar : PubMed/NCBI | |
|
Lin M, Ye M, Zhou J, Wang ZP and Zhu X: Recent advances on the molecular mechanism of cervical carcinogenesis based on systems biology technologies. Comput Struct Biotechnol J. 17:241–250. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ye J, Yin L, Xie P, Wu J, Huang J, Zhou G, Xu H, Lu E and He X: Antiproliferative effects and molecular mechanisms of troglitazone in human cervical cancer in vitro. Onco Targets Ther. 8:1211–1218. 2015.PubMed/NCBI | |
|
Yugawa T and Kiyono T: Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: Novel functions of E6 and E7 oncoproteins. Rev Med Virol. 19:97–113. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Jones MC, Askari JA, Humphries JD and Humphries MJ: Cell adhesion is regulated by CDK1 during the cell cycle. J Cell Biol. 217:3203–3218. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Hochegger H, Dejsuphong D, Sonoda E, Saberi A, Rajendra E, Kirk J, Hunt T and Takeda S: An essential role for Cdk1 in S phase control is revealed via chemical genetics in vertebrate cells. J Cell Biol. 178:257–268. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Vassilev LT: Cell cycle synchronization at the G2/M phase border by reversible inhibition of CDK1. Cell Cycle. 5:2555–2556. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Shaikh F, Sanehi P and Rawal R: Molecular screening of compounds to the predicted protein-protein interaction site of Rb1-E7 with p53-E6 in HPV. Bioinformation. 8:607–612. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Yun J, Chae HD, Choy HE, Chung J, Yoo HS, Han MH and Shin DY: p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor. J Biol Chem. 274:29677–29682. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Lindqvist A, van Zon W, Karlsson Rosenthal C and Wolthuis RM: Cyclin B1-Cdk1 activation continues after centrosome separation to control mitotic progression. PLoS Biol. 5:e1232007. View Article : Google Scholar : PubMed/NCBI | |
|
Crasta K, Huang P, Morgan G, Winey M and Surana U: Cdk1 regulates centrosome separation by restraining proteolysis of microtubule-associated proteins. EMBO J. 25:2551–2563. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Fang Y, Yu H, Liang X, Xu J and Cai X: Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer. Cancer Biol Ther. 15:1268–1279. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Krek W and Nigg EA: Differential phosphorylation of vertebrate p34cdc2 kinase at the G1/S and G2/M transitions of the cell cycle: Identification of major phosphorylation sites. EMBO J. 10:305–316. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Morgan DO: Principles of CDK regulation. Nature. 374:131–134. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Banerjee NS, Wang HK, Broker TR and Chow LT: Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes. J Biol Chem. 286:15473–15482. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Morgan EL, Wasson CW, Hanson L, Kealy D, Pentland I, McGuire V, Scarpini C, Coleman N, Arthur JSC, Parish JL, et al: STAT3 activation by E6 is essential for the differentiation-dependent HPV18 life cycle. PLoS Pathog. 14:e10069752018. View Article : Google Scholar : PubMed/NCBI | |
|
Stewart DA, Cooper CR and Sikes RA: Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer. Reprod Biol Endocrinol. 2:22004. View Article : Google Scholar : PubMed/NCBI | |
|
Chiu CF, Ho MY, Peng JM, Hung SW, Lee WH, Liang CM and Liang SM: Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane. Oncogene. 32:777–787. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Matter ML and Ruoslahti E: A signaling pathway from the alpha5beta1 and alpha(v)beta3 integrins that elevates bcl-2 transcription. J Biol Chem. 276:27757–27763. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2:161–174. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Sand JM, Larsen L, Hogaboam C, Martinez F, Han M, Røssel Larsen M, Nawrocki A, Zheng Q, Karsdal MA and Leeming DJ: MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis-validation of two novel biomarker assays. PLoS One. 8:e849342013. View Article : Google Scholar : PubMed/NCBI | |
|
Bokhari AA, Baker TM, Dorjbal B, Waheed S, Zahn CM, Hamilton CA, Maxwell GL and Syed V: Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-β signaling pathway. Oncotarget. 7:69733–69748. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
da Silva Cardeal LB, Brohem CA, Corrêa TC, Winnischofer SM, Nakano F, Boccardo E, Villa LL, Sogayar MC and Maria-Engler SS: Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence. Biochem Cell Biol. 84:713–719. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Cardeal LB, Boccardo E, Termini L, Rabachini T, Andreoli MA, di Loreto C, Longatto Filho A, Villa LL and Maria-Engler SS: HPV16 oncoproteins induce MMPs/RECK-TIMP-2 imbalance in primary keratinocytes: Possible implications in cervical carcinogenesis. PLoS One. 7:e335852012. View Article : Google Scholar : PubMed/NCBI | |
|
Shiau MY, Fan LC, Yang SC, Tsao CH, Lee H, Cheng YW, Lai LC and Chang YH: Human papillomavirus up-regulates MMP-2 and MMP-9 expression and activity by inducing interleukin-8 in lung adenocarcinomas. PLoS One. 8:e544232013. View Article : Google Scholar : PubMed/NCBI | |
|
Ding Y, Pan Y, Liu S, Jiang F and Jiao J: Elevation of MiR-9-3p suppresses the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via down-regulating FN1, ITGB1 and ITGAV. Cancer Biol Ther. 18:414–424. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Deng L, Huang J, Cai R, Zhu X, Liu F, Wang Q, Zhang J and Zheng Y: High expression of Fibronectin 1 suppresses apoptosis through the NF-κB pathway and is associated with migration in nasopharyngeal carcinoma. Am J Transl Res. 9:4502–4511. 2017.PubMed/NCBI | |
|
Rajkumar T, Sabitha K, Vijayalakshmi N, Shirley S, Bose MV, Gopal G and Selvaluxmy G: Identification and validation of genes involved in cervical tumourigenesis. BMC Cancer. 11:802011. View Article : Google Scholar : PubMed/NCBI | |
|
Koromilas AE and Sexl V: The tumor suppressor function of STAT1 in breast cancer. JAKSTAT. 2:e233532013.PubMed/NCBI | |
|
Zhang Y and Liu Z: STAT1 in cancer: Friend or foe? Discov Med. 24:19–29. 2017.PubMed/NCBI | |
|
Akram M, Kim KA, Kim ES, Shin YJ, Noh D, Kim E, Kim JH, Majid A, Chang SY, Kim JK and Bae ON: Selective inhibition of JAK2/STAT1 signaling and iNOS expression mediates the anti-inflammatory effects of coniferyl aldehyde. Chem Biol Interact. 256:102–110. 2016. View Article : Google Scholar : PubMed/NCBI |
